Post-Irradiation Treatment with a Superoxide Dismutase Mimic, MnTnHex-2-PyP5+, Mitigates Radiation Injury in the Lungs of Non-Human Primates after Whole-Thorax Exposure to Ionizing Radiation
J. Mark Cline(Wake Forest University), Željko Vujašković(Harvard University), Kouros Owzar(Duke University), Donna L. Perry(National Institutes of Health), Ashley A. Weaver(Wake Forest University), Artak Tovmasyan(Barrow Neurological Institute), Ines Batinic̈‐Haberle(Duke University), Ivan Spasojević(Duke University), Jiang Chen(Duke University), Greg Dugan(Wake Forest University), J. Daniel Bourland(Radiation Oncology Associates), Joel D. Stitzel(Wake Forest University)
Cited by 37
Related Papers
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
|Journal of Clinical Oncology|2008|655
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
|Journal of Clinical Oncology|2009|507